Another recent study suggested that silencing the HOXA11-AS activity via a Wnt signaling pathway might have an antitumor effect and suppress the development of HCC by decreasing the methylation level of the promoter region of HOXA11 [23]. Here, HOXA11 is linked to hepatocellular carcinoma.